Mizuho yesterday lowered the firm’s price target on Delek US (DK) to $22 from $25 and keeps a Neutral rating on the shares. The firm expects Delek US to miss current consensus earnings estimates for EBITDA and earnings by 89% and 21%, respectively. The company’s improvement in indicator margins will be partly offset by guided-higher operating expenses, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK: